Get 40% Off
👀 👁 🧿 All eyes on Biogen, up +4,56% after posting earnings. Our AI picked it in March 2024.
Which stocks will surge next?
Unlock AI-picked Stocks

Trump Proposes 2020 Budget: ETFs To Top & Flop

Published 03/11/2019, 11:05 PM
Updated 07/09/2023, 06:31 AM

President Donald Trump unveiled his third budget proposal for fiscal 2020, which begins on Oct 1, 2019. The record $4.75 trillion budget proposal seeks to bolster funding for defense and border walls while cutting down on social and domestic programs like education and environmental protection. The large reduction of $1.1 trillion will come from lower spending on discretionary domestic programs, outside of the military, over the course of a decade.

This draft budget, called “A Budget for a Better America,” has more reductions in spending than any president in history has ever proposed, underscoring concern about the national debt. Notably, the deficit has amplified under Republican leadership because of the tax cuts enacted last year. The proposal aims significant economic growth over the next decade say at about 3% annually, with the expectation that the government will continue to enact tax cuts and a deregulatory agenda.

Here are the key takeaways from the budget and their expected impact on ETFs:

Defense Spending Boost

Trump has proposed a 5% or $34 million increase in defense spending to a total of $750 billion, up from $716 billion. The blueprint also aims to increase spending in Veterans Affairs and Homeland Security.

The draft plan comes across as a boon for the aerospace sector, which currently belongs to a top-ranked Zacks industry (in the top 13%). Defense ETFs – PowerShares Aerospace & Defense Portfolio PPA, iShares U.S. Aerospace & Defense ETF (HM:ITA) and SPDR S&P Aerospace & Defense ETF (LON:XAR) are thus expected to surge. PPA has a Zacks ETF Rank #3 (Hold) while ITA and XAR have a Zacks ETF Rank #2 (Buy) (read: Why Aerospace & Defense ETFs are Soaring in 2019).

Boost for Mexico Border Wall

Trump’s blueprint outlines $8.6 billion for the border wall between the U.S. and Mexico - more than six times received in each of the past two fiscal years. This will hurt iShares MSCI Mexico Capped ETF EWW, which offers a diversified exposure to Mexican stocks. The fund has a Zacks ETF Rank #3.

Historic Spending Cuts

The government agencies that will see drastic cuts in their spending, including 31% in Environmental Protection Agency (EPA), 23% in the State Department, 22% in the Transportation Department, 16% in Housing and Urban Development, 15% in the Interior Department, and 12% in the Health and Human Services Department (read: Homebuilder ETFs Shining Ahead of Spring Selling Season).

The reductions will likely impact ETFs covering various corners of the space. Notable among these may be First Trust NASDAQ Clean Edge Green Energy Index Fund QCLN, PowerShares WilderHill Clean Energy Portfolio PBW and VanEck Vectors Agribusiness ETF MOO. QCLN has a Zacks ETF Rank #3.

Additionally, the Trump administration has requested for deep spending cuts at many federal science agencies, including a 13% cut for the National Institutes of Health (NIH) and a 12% cut for the National Science Foundation (NSF) for the third year in a row. The reduction is expected to hurt several ETFs from the healthcare sector such as The Loncar Cancer Immunotherapy ETF CNCR, Principal Healthcare Innovators Index ETF BTEC, VanEck Vectors Generic Drugs ETF GNRX, iShares Evolved U.S. Innovative Healthcare ETF IEIH and Virtus LifeSci Biotech Clinical Trials ETF (MZ:BBC) . BTEC and BBC have a Zacks ETF Rank #2.

Reduction in Discretionary Programs for Poor

The proposed budget is detrimental to the poor and the disabled. It includes reduction over the next decade of $1.5 trillion in Medicaid and $845 billion in Medicare; $25 billion in Social Security, including cuts for disability insurance; $220 billion in Supplemental Nutrition Assistance Program (commonly known as food stamps); a $21 billion cut in Temporary Assistance for Needy Families program (commonly known as welfare) and $207 billion in the student loan program.

Consumer Staples Select Sector SPDR Fund XLP could be in trouble if food and nutritional assistance funding is slashed as the ETF offers exposure to essential products across America. XLP has a Zacks ETF Rank #1. Additionally, Barclays (LON:BARC) Return on Disability ETN (SIX:RO) , providing exposure to companies that attract and hire people with disabilities along with their friends and family as customers and employees, will also be hit hard.

Elimination of EV Tax Credit

The Trump administration also proposed to eliminate a tax credit worth up to $7,500 on the purchase of new electric vehicles, a move it says will save the U.S. government $2.5 billion over a decade. However, it will likely take a toll on automakers. First Trust NASDAQ Global Auto ETF CARZ, offering pure play global exposure to auto stocks, will be on investors’ radar. The fund has a Zacks ETF Rank #3 (read: 10 ETF Areas to Gain as Trump Delays Additional Tariffs).

Want key ETF info delivered straight to your inbox?

Zacks’ free Fund Newsletter will brief you on top news and analysis, as well as top-performing ETFs, each week.Get it free >>

First Trust NASDAQ Clean Edge Green Energy Index Fund (QCLN): ETF Research Reports

iShares U.S. Aerospace & Defense ETF (ITA): ETF Research Reports

Principal Healthcare Innovators Index ETF (BTEC): ETF Research Reports

Loncar Cancer Immunotherapy ETF (CNCR): ETF Research Reports

Consumer Staples Select Sector SPDR Fund (XLP): ETF Research Reports

VanEck Vectors Generic Drugs ETF (GNRX): ETF Research Reports

Virtus LifeSci Biotech Clinical Trials ETF (BBC): ETF Research Reports

iShares MSCI Mexico ETF (EWW): ETF Research Reports

Invesco WilderHill Clean Energy ETF (NYSE:XLE) (PBW): ETF Research Reports

SPDR S&P Aerospace & Defense ETF (XAR): ETF Research Reports

VanEck Vectors Agribusiness ETF (MOO): ETF Research Reports

First Trust NASDAQ Global Auto Index Fund (CARZ): ETF Research Reports

Invesco Aerospace & Defense ETF (PPA): ETF Research Reports

iShares Evolved U.S. Innovative Healthcare ETF (IEIH): ETF Research Reports

Original post

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.